Results 131 to 140 of about 125,761 (305)

NORMAN-SLE (Suspect List Exchange) Update for NORMAN GA in Milan, Nov 2019

, 2019
A slide set to update NORMAN members of progress made on the NORMAN Suspect List Exchange (NORMAN-SLE) in 2019. To be presented by Jaroslav Slobodnik on my behalf.
SCHYMANSKI, Emma, Schymanski, Emma (6548762)   +1 more
core   +1 more source

Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification

Arthritis &Rheumatology, EarlyView.
Objective Proteome‐wide risk models for lupus remain underexplored. We developed classification models to identify lupus from serum proteomic profiles. Methods Patients with lupus and individuals with other autoimmune diseases in the UK Biobank were included.
Mehmet Hocaoǧlu, Jishnu Das, Amr H. Sawalha   +2 more
wiley   +1 more source

S53 | UFZWANATARG | Target Compounds from UFZ WANA

, 2019
<p>This is the collection associated with list S53 UFZWANATARG on the NORMAN Suspect List Exchange.</p> <p><a href="https://www.norman-network.com/nds/SLE/">https://www.norman-network.com/nds/SLE/</a></p> <p> ...
Krauss, Martin (6656855), Schulze, Tobias, Krauss, Martin, Schulze, Tobias (6548798)   +3 more
core   +1 more source

Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA‐Reporter Assay

Arthritis &Rheumatology, EarlyView.
Objective Immune complexes (ICs), formed by autoantigen and autoantibody, play a pathogenic role in systemic autoimmune diseases through stimulation of Fcγ receptors (FcγR). However, studies investigating bioactivity of circulating ICs across various diseases remain limited.
Koji Suzuki, Masaru Takeshita, Yuki Imai, Hiroyuki Fukui, Kazunori Furuhashi, Kotaro Matsumoto, Jun Kikuchi, Keiko Yoshimoto, Yuko Kaneko   +8 more
wiley   +1 more source

Anifrolumab in the treatment of recurrent systemic lupus erythematosus: the first post-trial case report

Central European Journal of Immunology
Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease whose treatment is still a challenge. The latest registration of anifrolumab for the treatment of moderate-to-severe SLE raises hopes because of its novel anti-interferon ...
Przemysław Borowy, Alicja Kamińska, Patrycja Major, Jakub Smyk, Katarzyna Gołojuch, Bogdan Batko   +5 more
doaj   +1 more source

AhR in SLE [PDF]

Nature Reviews Nephrology, 2018
openaire   +2 more sources

Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation

, 2001
Data related to the disease course of patients with systemic lupus erythematosus (SLE) with special attention to the persistence of disease activity in the long term are scarce.
Z. DOMJLIAN, B. ANIC, Mosca, M, D. LOGAR, JS SMOLEN, Chwalinska-Sadowska, H, RJT SMEENK, B. ROZMAN, M. SCHNEIDER, E. KISS, van den Brink, HG, Graninger, W, Fischer, R, Kalden, JR, Smolen, JS, Moutsopoulos, HM, Cikes, N, K. MANGER, R. FISCHER, Bombardieri, S, G. POKORNY, W. GRANINGER, Anic, B, S. TOSI, H. CHWALINSKA SADOWSKA, Kiss, E, Swaak, AJG, AJ SWAAK, BOMBARDIERI, STEFANO, Logar, D, Rozman, B, Domljan, Z, Kovacs, L, HM MOUTSOPOULOS, Manger, K, Pokorny, G, Vlachoyiannopoulos, PG, JR KALDEN, Smeenk, RJT, Kovacs, A, Tosi, S, N. CIKES, Schneider, M, L. KOVACS, PG VLACHOYIANNOPOULOS, MOSCA, MARTA, HG VAN DEN BRINK   +46 more
core  

SLE B cell transcriptomes.

, 2013
Hierarchical cluster dendrogram of expressed genes that differed significantly between peripheral blood CD19+ B cells isolated from SLE patients and healthy controls (HC). The SLE samples are ordered by increasing SLEDAI score.
Yun Lian (426062), David R. Karp (426065), Amy M. Becker (196481), J. David Farrar (426067), Anne B. Satterthwaite (426068), Fatema Z. Chowdhury (426066), Andreas M. Reimold (426063), Chandra Mohan (157054), Nancy J. Olsen (426064), Roger Kornu (426059), Shuchi Lakhanpal (426060), Quan-Zhen Li (425822), Peter E. Lipsky (58962), Tianfu Wu (156995), Edward K. Wakeland (396829), Angela B. Mobley (426061), Kathryn H. Dao (426057), Bobby Kwanghoon Han (426058), Laurie S. Davis (426069)   +18 more
core   +1 more source

Kidney Hematopoietic Stem and Progenitor Cells Contribute to Myeloid Development and Pathology in Lupus Nephritis

Arthritis &Rheumatology, EarlyView.
Objective The hematopoietic system maintains homeostasis by balancing myeloid and lymphoid cell production in the bone marrow (BM). In response to increased hematopoietic demand, extramedullary hematopoiesis (EMH) may occur in nonlymphoid organs. We investigated the role of EMH and kidney‐resident hematopoietic stem and progenitor cells (HSPCs) in ...
Hansol Yi, Seyoung Jung, Jeong Ho Joo, Young‐Eun Kim, Heounjeong Go, Yong‐Gil Kim, Chang‐Keun Lee, Bin Yoo, Jeong Seok Lee, Seokchan Hong   +9 more
wiley   +1 more source

Cardiovascular Issues in SLE

, 2016
Cardiovascular disease is a significant cause of morbidity and mortality in systemic lupus erythematosus (SLE) patients. Both traditional cardiovascular risk factors and SLE-specific related risk factors contribute to an accelerated atherosclerosis ...
Maria Gerosa, Tincani, Angela, Meroni, Pier Luigi, M. Gerosa, Angela Tincani, Taraborelli, Mara, Mara Taraborelli, Pier Luigi Meroni   +7 more
core   +1 more source